Donald Morris, University of Calgary

Research

Epigenetics Mgmt Olaparib Parp Inhibition Targeted Treatment Temozolomide Triple Negative Breast Cancer

Latest papers

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2007

All 1 publications

Latest funding

MGMT promoter methylated breast cancer: An opportunity for a targeted treatment with alkylating agent temozolomide in combination with existing breast cancer therapeutics.
CIHR · 2018 · Nominated PI
$852,300
Alberta Physical Activity and Breast Cancer Prevention Trial: Ancillary Study Examining the Effect of Exercise on Oxidative Stress, Telomere Length and DNA Methylation
CIHR · 2013 · Co-investigator
$608,490
The ING Epigenetic Chromatin Regulators in Apoptosis and Oncolysis
CIHR · 2009 · Principal investigator

All 3 grants and awards

1 publications.

01

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis.

Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2007

DOI: 10.1016/j.bbmt.2006.10.017 PMID: 17317583

MGMT promoter methylated breast cancer: An opportunity for a targeted treatment with alkylating agent temozolomide in combination with existing breast cancer therapeutics.

Nominated PICIHR2018Operating Grant: Epigenetics Clinical Translation

Principal investigators: Morris, Donald G; Verma, Sunil

Keywords: Epigenetics; Mgmt; Olaparib; Parp Inhibition; Targeted Treatment; Temozolomide; Triple Negative Breast Cancer

$852,300

Alberta Physical Activity and Breast Cancer Prevention Trial: Ancillary Study Examining the Effect of Exercise on Oxidative Stress, Telomere Length and DNA Methylation

Co-investigatorCIHR2013Operating Grant

Principal investigators: Friedenreich, Christine M

Keywords: Antioxidant Enzymes; Breast Cancer Epidemiology; Cancer Biomarkers; Dna Damage Response; Dna Methylation; Oxidative Stress; Physical Activity; Randomized Controlled Trial; Telomerase; Telomere Length

$608,490

The ING Epigenetic Chromatin Regulators in Apoptosis and Oncolysis

Principal investigatorCIHR2009Team Grant: Terry Fox New Frontiers Program in Cancer (LOI)

Principal investigators: Riabowol, Karl T; Lees-Miller, Susan P; Morris, Donald G

Keywords: Apoptosis; Chromatin Regulation; Hdac Inhibitors -Dna Damage And Repair; Ing1 Tumor Suppressor; Mechanism; Model Systems

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Epigenetics Dear Professor Morris, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis." (2007), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]